Role of CD40-dependent down-regulation of CD154 in impaired induction of CD154 in CD4+ T cells from HIV-1-infected patients

Journal of Immunology

Volumn 178, Issue 3, 2007, Pages 1645-1653

  Subauste, Carlos S ^a,b   Subauste, Angela ^c   Wessendarp, Matthew ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; MESSENGER RNA;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 33846556939     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.3.1645     Document Type: Article

References (38)

1. van Kooten, C., and J. Banchereau. 2000. CD40-CD40 ligand. J. Leukocyte Biol. 67: 2-17.
2. Grewal, I. S., and R. A. Flavell. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16: 111-135.
3. Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, and S. Nonoyama. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72: 291-300.
4. Levy, J., T. Espanol-Boren, C. Thomas, A. Fischer, P. Tovo, P. Bordigoni, I. Resnick, A. Fasth, M. Baer, L. Gomez, et al. 1997. Clinical spectrum of X-linked hyper-IgM syndrome. J. Pediatr. 131: 47-54.
5. Subauste, C. S., M. Wessendarp, R. U. Sorensen, and L. Leiva. 1999. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type-1 immune response which can be restored by soluble CD40L trimer. J. Immunol. 162: 6690-6700.
6. Jain, A., T. Prescott Atkinson, P. E. Lipsky, J. E. Slater, D. L. Nelson, and W. Strober. 1999. Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome. J. Clin. Invest. 103: 1151-1158.
7. Perez-Melgosa, M., D. Hollenbaugh, and C. B. Wilson. 1999. CD40 ligand is a limiting factor in the humoral response to T cell-dependent antigens. J. Immunol. 163: 1123-1127.
8. Yellin, M. J., K. Sippel, G. Inghirami, L. R. Covey, J. J. Lee, J. Sinning, E. A. Clark, L. Chess, and S. Lederman. 1994. CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L: potential role in regulating helper effector function. J. Immunol. 152: 598-608.
9. van Kooten, C., C. Gaillard, J. P. Galizzi, P. Hermann, F. Fossiez, J. Banchereau, and D. Blanchard. 1994. B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40. Eur. J. Immunol. 24: 787-792.
10. + T cells with dendritic cells. Eur. J. Immunol. 26: 3137-3143.
11. + T cell counts. J. Infect. Dis. 164: 631-637:
12. + T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J. Infect. Dis. 172: 79-87.
13. Wolthers, K. C., S. A. Otto, S. M. A. Lens, R. A. W. van Lier, F. Miedema, and L. Meyaard. 1997. Functional B cell abnormalities in HIV type 1 infection: role of CD40L and CD70. AIDS Res. Hum. Retroviruses 12: 1023-1029.
14. Vanham, G., L. Penne, J. Devalck, L. Kestens, R. Colebunders, E. Bosmans, K. Thielemans, and J. L. Ceuppens. 1999. Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection. Clin. Exp. Immunol. 117: 335-342.
15. Subauste, C. S., M. Wessendarp, A. G. Smulian, and P. T. Frame. 2001. Role of CD40 ligand signaling in defective type-1 cytokine response in HIV infection. J. Infect. Dis. 183: 1722-1731.
16. O'Gorman, M. R., B. Du Chateau, M. Paniagua, J. Hunt, N. Bensen, and R. Yogev. 2001. Abnormal CD40 ligand (CD154) expression in human immunodeficiency virus-infected children. Clin. Diag. Lab. Immunol. 8: 1104-1109.
17. + T cells from HIV-infected individuals. J. Infect. Dis. 189: 61-70.
18. Zhang, R., C. J. Fichtenbaum, D. A. Hildeman, J. D. Lifson, and C. Chougnet. 2004. CD40 ligand dysregulation in HIV: HIV glycoprotein 120 inhibits signaling cascades upstream of CD40 ligand transcription. J. Immunol. 172: 2678-2686.
19. + individuals to express CD40 ligand after in vitro stimulation is not impaired. Clin. Immunol. Immunopathol. 74: 112-114.
20. + T cell help in HIV-infected individuals. Proc. Natl. Acad. Sci. USA 100: 6057-6062.
21. Subauste, C. S., F. Fuh, R. de Waal Malefyt, and J. S. Remington. 1998. αβ T cell response to Toxoplasma gondii in previously unexposed individuals. J. Immunol. 160: 3403-3411.
22. Subauste, C. S., and M. Wessendarp. 2000. Human dendritic cells discriminate between viable and killed Toxoplasma gondii tachyzoites: dendritic cell activation after infection with viable parasites results in CD28 and CD40 ligand signaling that controls IL-12-dependent and -independent T cell production of IFN-γ. J. Immunol. 165: 1498-1505.
23. Andrade, R. M., J.-A. C. Portillo, M. Wessendarp, and C. S. Subauste. 2005. CD40 signaling in macrophages induces anti-microbial activity against an intracellular pathogen independently of IFN-γ and reactive nitrogen intermediates. Infect. Immun. 73: 3115-3123.
24. Okada, M., K. Suzuki, K. Takada, M. Nakashima, T. Nakanishi, and T. Shinohara. 2005. Detection of up-regulated genes in thrombin-stimulated human umbilical vein endothelial cells. Thromb. Res. 118: 715-721.
25. Crow, M. K., and K. A. Kirou. 2001. Regulation of CD40 ligand expression in systemic lupus erythematosus. Curr. Opin. Rheumatol. 13: 361-369.
26. Alderson, M. R., R. J. Armitage, T. W. Tough, L. Strockbine, W. C. Fanslow, and M. K. Spriggs. 1993. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178: 669-674.
27. Morrissey, P. J., L. Bressler, K. Charrier, and A. Alpert. 1988. Response of resident murine peritoneal macrophages to in vivo administration of granulocyte-macrophage colony-stimulating factor. J. Immunol. 140: 1910-1915.
28. Pinchuk, L. M., P. S. Polacino, M. B. Agy, S. J. Klaus, and E. A. Clark. 1994. The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV Infect. Immunity 1: 317-325.
29. Pullen, S. S., M. E. Labadia, R. H. Ingraham, S. M. McWhirter, D. S. Everdeen, T. Alber, J. J. Crute, and M. R. Kehry. 1999. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization. Biochemistry 38: 10168-10177.
30. Kadono, Y., F. Okada, C. Perchonock, H. D. Jang, S. Y. Lee, N. Kim, and Y. Choi. 2005. Strength of TRAF6 signalling determines osteoclastogenesis. EMBO Rep. 6: 171-176.
31. Ahlers, J. D., I. M. Belyakov, E. K. Thomas, and J. A. Berzofsky. 2001. High-affinity T helper epitope induces complementary helper and APC polarization, increased CTL, and protection against viral infection. J. Clin. Invest. 108: 1677-1685.
32. + T cell proliferation and production of IFN-γ in response to p24 antigen in HIV-infected individuals: potential contribution of anergy to HIV-specific un responsiveness. J. Immunol. 165: 1685-1691.
33. + T cell responses. J. Immunol. 165: 6133-6141.
34. Subauste, C. S. 2002. CD154 and type-1 cytokine response: from hyper IgM syndrome to human immunodeficiency virus infection. J. Infect. Dis. 185; S83-S89.
35. Graf, D., S. Muller, U. Korthauer, C. van Kooten, C. Weise, and R. A. Kroczek. 1995. A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. Eur. J. Immunol. 25: 1749-1754.
36. Amcheslavsky, A., W. Zou, and Z. Bar-Shavit. 2004. Toll-like receptor 9 regulates tumor necrosis factor-α expression by different mechanisms. J. Biol. Chem. 279: 54039-54045.
37. Cantwell, M., T. Hua, J. Pappas, and T. J. Kipps. 1997. Acquired CD40-ligand deficiency in chronic lymphocytic leukemia. Nat. Med. 3: 984-989.
38. Chehimi, J., S. E. Starr, A. Frank, A. D'Andrea, X. Ma, R. R. MacGregor, J. Sennelier, and G. Trinchieri. 1994. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 179: 1361-1366.